{"text": ["Abbvie's", "deal", "for", "Allergan", "clears", "U.S.", "antitrust", "hurdle"], "created_at": "2020-05-05 22:14:00"}
{"text": ["Abbvie's", "deal", "for", "Allergan", "clears", "U.S.", "antitrust", "hurdle"], "created_at": "2020-05-05 22:14:00"}
{"text": ["AbbVie", "and", "Allergan", "Receive", "Clearance", "from", "U.S.", "Federal", "Trade", "Commission", "for", "AbbVie's", "Acquisition", "of", "Allergan"], "created_at": "2020-05-05 21:51:00"}
{"text": ["Form", "8.3", "-", "AbbVie", "Inc."], "created_at": "2020-05-05 12:08:00"}
{"text": ["AbbVie", "Receives", "Health", "Canada", "Approval", "for", "the", "Combination", "of", "VENCLEXTA\u00ae", "(venetoclax)", "with", "Obinutuzumab", "for", "Patients", "with", "Previously", "Untreated", "Chronic", "Lymphocytic", "Leukemia"], "created_at": "2020-05-05 11:01:00"}
{"text": ["Form", "8.3", "-", "ABBVIE", "INC"], "created_at": "2020-05-05 10:59:00"}
